SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-05-234152
Filing Date
2005-11-30
Accepted
2005-11-30 14:26:24
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ds3.htm S-3 237241
2 OPINION OF O'MELVENY & MYERS LLP dex51.htm EX-5.1 3745
3 LETTER REGARDING UNAUDITED FINANCIAL INFORMATION dex151.htm EX-15.1 3129
4 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2015
5 CONSENT OF GRANT THORNTON LLP, INDEPENDENT AUDITORS dex232.htm EX-23.2 2012
6 GRAPHIC g51766img_1.jpg GRAPHIC 22559
  Complete submission text file 0001193125-05-234152.txt   280749
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-130004 | Film No.: 051234036
SIC: 2834 Pharmaceutical Preparations